The Food and Drug Administration (FDA) is preparing to grant emergency use clearance to Pfizer to apply its COVID-19 vaccine to 11-year-olds. or less.
According to the leading infectious disease expert in the United States, Dr. Anthony Fauci, the authorization would be given in November.
On the other hand, Moderna’s vaccine could receive approval a few weeks after Pfizer, Fauci said at a live event with the New York Times.
Pfizer and Moderna have been conducting clinical studies for months in age groups between 9 and 11 years, 6 and 9 years, 2 and 6 years, and babies from six months of age.
Once manufacturers complete the relevant part of their clinical trials, manufacturers must complete the analysis of the study data to understand how safe the vaccine is and how effective it is in the participants in the clinical trial.
Fauci advanced a few weeks ago that President Joe Biden’s government plan remains “in some respects” to begin third doses the week of September 20th.